Kenneth Anderson

Founder at C4 THERAPEUTICS, INC.

Net worth: 2 M $ as of 2026-05-30

74 year

69 connections

Commercial Services

Health Technology

Consumer Services

Profile

Kenneth C.
Anderson is the founder of Acetylon Pharmaceuticals, Inc., founded in 2008, serving as Director since 2008.
Dr. Anderson is the founder of C4 Therapeutics, Inc., founded in 2015, serving as Independent Director since 2015.
Dr. Anderson is the founder of NextRNA Therapeutics, Inc., founded in 2021, serving as Director since 2021.
Dr. Anderson is also the founder of Dynamic Cell Therapies, Inc...
Dr. Anderson is currently Director-Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute, Inc. Dr. Anderson is Director at The Multiple Myeloma Research Foundation, Inc. since 2011.
Dr. Anderson is Director at Mana Therapeutics, Inc. since 2018.
Dr. Anderson is Director at Raqia Therapeutics, Inc. since 2020.
Dr. Anderson is Director at Starton Therapeutics, Inc. since 2020.
Dr. Anderson is a Member of the National Academy of Medicine (United States).
Dr. Anderson is Professor at Harvard Medical School since 2002.
Former positions include Chairman at Multiple Myeloma Research Consortium, Chairman at National Comprehensive Cancer Network, Inc., Director at OncoPep, Inc., President at American Society of Hematology, and President at International Myeloma Society from 2011 to 2015.
Education includes a doctorate from The Johns Hopkins University School of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
C4 THERAPEUTICS, INC. 0.32%	2026-05-31	355,585 ( 0.32% )	2 M $	2026-05-30

Kenneth Anderson active positions

Companies	Position	Start
C4 THERAPEUTICS, INC.	Founder	2014-12-31
The Multiple Myeloma Research Foundation, Inc. The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment	Director/Board Member	-
Raqia Therapeutics, Inc. Raqia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops and manufactures oncology therapeutics	Director/Board Member	2020-08-31
NextRNA Therapeutics, Inc. NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services	Founder	2021-01-31
Starton Therapeutics, Inc. Starton Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on transforming therapies with delivery technology	Director/Board Member	2020-08-31
National Academy of Medicine (United States) National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization	Corporate Officer/Principal	-
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	2001-12-31
Dana-Farber Cancer Institute, Inc. Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients	Corporate Officer/Principal	2010-11-30
Mana Therapeutics, Inc. Mana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical cell immune therapies that can eliminate cancer cells	Director/Board Member	2017-12-31
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░	░░░░░░░░░░

All active positions of Kenneth Anderson

Former positions of Kenneth Anderson

Companies	Position	End
░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░	░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░	░░░░░░░	-
░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░	░░░░░░░░	-
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░	░░░░░░░░	-
░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Kenneth Anderson's experience

Training of Kenneth Anderson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kenneth Anderson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	17
OncoPep, Inc. OncoPep, Inc. Investment ManagersFinance Functions as an alternative investment manager	Finance
Dana-Farber Cancer Institute, Inc. Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients	Health Services
National Academy of Medicine (United States) National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization	Commercial Services
American Society of Hematology American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation	Commercial Services
The Multiple Myeloma Research Foundation, Inc. The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment	Commercial Services
Multiple Myeloma Research Consortium Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Provides research and drug development	Commercial Services
National Comprehensive Cancer Network, Inc. National Comprehensive Cancer Network, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to fight against cancer	Commercial Services
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Acetylon Pharmaceuticals, Inc. Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technology	Health Technology
The Johns Hopkins University School of Medicine The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
C4 Therapeutics, Inc. C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer	Health Technology
Mana Therapeutics, Inc. Mana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical cell immune therapies that can eliminate cancer cells	Commercial Services
Raqia Therapeutics, Inc. Raqia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops and manufactures oncology therapeutics	Commercial Services
International Myeloma Society International Myeloma Society The International Myeloma Society is a professional, scientific, and medical organization dedicated to advancing research, education, and clinical care related to multiple myeloma and plasma cell disorders. The private company is based in Rochester. The society brings together basic scientists, clinical investigators, physicians, and healthcare practitioners worldwide to promote collaboration and knowledge exchange through workshops, conferences, symposia, and educational events. It provides membership benefits such as access to meeting materials, member directories, and newsletters, and supports the myeloma community by funding translational and career development research awards. The society addresses disparities in treatment access through programs like the Therapeutic Map, which offers region-specific drug availability guidelines for clinicians. It organizes annual meetings and thematic sessions with expert talks and collaborative discussions with regulatory agencies, focusing on topics such as genomics and novel therapies.
Starton Therapeutics, Inc. Starton Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on transforming therapies with delivery technology	Health Technology
NextRNA Therapeutics, Inc. NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services	Health Technology
Dynamic Cell Therapies, Inc. Dynamic Cell Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pre-clinical stage biopharmaceutical company	Health Technology